The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Halogenation of Drugs Enhances Membrane Binding and Permeation
Abstract
Halogenation of drugs is commonly used to enhance membrane binding and permeation. We quantify the effect of replacing a hydrogen residue by a chlorine or a trifluoromethyl residue in position C‐2 of promazine, perazine, and perphenazine analogues. Moreover, we investigate the influence of the position (C‐6 and C‐7) of residue CF3 in benzopyranols. The twelve drugs are characterized by surface activity measurements, which yield the cross‐sectional area, the air–water partition coefficient, and the critical micelle concentration. By using the first two parameters (AD and Kaw) and the appropriate membrane packing density, the lipid–water partition coefficients, are calculated in excellent agreement with the lipid–water partition coefficients measured by means of isothermal titration calorimetry for small unilamellar vesicles of 1‐palmitoyl‐2‐oleoyl‐sn‐glycero‐3‐phosphocholine. Replacement of a hydrogen residue by a chlorine and a trifluoromethyl residue enhances the free energy of partitioning into the lipid membrane, on average by Δ Glw≈−1.3 or −4.5 kJ mol−1, respectively, and the permeability coefficient by a factor of ∼2 or ∼9, respectively. Despite exhibiting practically identical hydrophobicities, the two benzopyranol analogues differ in their permeability coefficients by almost an order of magnitude; this is due to their different cross‐sectional areas at the air–water and lipid–water interfaces.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Encyclopedia of physical science and technology
(2002) · Choice Reviews Online · doi:10.5860/choice.39-3718 · Cited by 2,087
Marsh, D. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00009-3 · Cited by 1,108
The Electrostatic Properties of Membranes
McLaughlin, S. (1989) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.18.060189.000553 · Cited by 1,071
Electrostatic Potentials at Membrane-Solution Interfaces
McLaughlin, S. (1977) · Current Topics in Membranes and Transport · doi:10.1016/s0070-2161(08)60677-2 · Cited by 825
Demel, R. A., Geurts van Kessel, W. S. M., Zwaal, R. F. A., Roelofsen, B., & van Deenen, L. L. M. (1975) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(75)90045-0 · Cited by 562
Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion
Fischer, H., Gottschlich, R., & Seelig, A. (1998) · Journal of Membrane Biology · doi:10.1007/s002329900434 · Cited by 371
Self-citationLocal anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers
Seelig, A. (1987) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(87)90400-7 · Cited by 278
Self-citationGobas, F. A. P. C., Lahittete, J. M., Garofalo, G., Shiu, W. Y., & Mackay, D. (1988) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600770317 · Cited by 228
A method to determine the ability of drugs to diffuse through the blood-brain barrier.
Seelig, A., Gottschlich, R., & Devant, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.68 · Cited by 197
Self-citationpKaValues of Medicinal Compounds in Pharmacy Practice
Newton, D. W., & Kluza, R. B. (1978) · Drug Intelligence & Clinical Pharmacy · doi:10.1177/106002807801200906 · Cited by 186
Determination of acidity constants
Cookson, R. F. (1974) · Chemical Reviews · doi:10.1021/cr60287a002 · Cited by 162
Boguslavsky, V., Rebecchi, M. J., Morris, A. J., Jhon, D. Y., Rhee, S. G., & McLaughlin, S. (1994) · Biochemistry · doi:10.1021/bi00176a036 · Cited by 120
Franke, U., Munk, A., & Wiese, M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980206m · Cited by 51
Cited by
Halogen atoms in the modern medicinal chemistry: hints for the drug design
Hernandes, M., Cavalcanti, S. M., Moreira, D. R., de Azevedo Junior, W., & Leite, A. C. (2010) · Current Drug Targets · doi:10.2174/138945010790711996 · Cited by 723
Soteras Gutiérrez, I., Lin, F.-Y., Vanommeslaeghe, K., Lemkul, J. A., Armacost, K. A., Brooks, C. L., & MacKerell, A. D. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.06.034 · Cited by 283
Matter, H., Nazaré, M., Güssregen, S., Will, D. W., Schreuder, H., Bauer, A., Urmann, M., Ritter, K., Wagner, M., & Wehner, V. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200806219 · Cited by 274
Fluorine Bonding — How Does It Work In Protein−Ligand Interactions?
Zhou, P., Zou, J., Tian, F., & Shang, Z. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci9002393 · Cited by 263
Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
Bergström, C. A. S., Holm, R., Jørgensen, S. A., Andersson, S. B. E., Artursson, P., Beato, S., Borde, A., Box, K., Brewster, M., Dressman, J., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.015 · Cited by 257
Metadata
- Authors
- Gerebtzoff, G., Li‐Blatter, X., Fischer, H., Frentzel, A., & Seelig, A.
- Venue
- ChemBioChem
- Publisher
- Wiley
- Published
- 2004-04-28
- Volume
- 5
- Issue
- 5
- Pages
- 676-684
- ISSN
- 1439-4227 (ISSN-L)
- 1439-7633
- OpenAlex
- W2119892971
- Cited by
- 271
- References
- 13
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.